Russian vaccine

Published August 14, 2020

AS countries race to produce the first coronavirus vaccine, Russia’s claims that it has approved such a vaccine have been met with serious scepticism — and for good reason. Russia announced this week that the Sputnik V coronavirus vaccine has been given the green signal for extensive use and that the country was forging ahead with mass manufacturing and immunisation plans to kick off vaccination as early as October. President Vladimir Putin said the locally developed vaccine was given regulatory approval after less than two months of testing on humans, but that it had purportedly passed all the required checks. To silence naysayers, he added that his daughter had already been administered a dose. Worryingly, the head of the country’s sovereign wealth fund said there are international agreements to produce 500m doses and requests for 1bn doses from 20 countries. The announcement has sparked legitimate fears among experts, who said the Russian vaccine has bypassed ‘phase 3’ — a crucial trial stage which mass-tests an under-research vaccine on thousands of people to observe its efficacy. Professors and medical experts from reputable institutions have expressed concern over several aspects of this vaccine, and called into question the process through which it was approved. Some fear it is difficult to know how safe or effective it will be given that the work that went into its development was not transparent. The WHO has said vaccines must go through all stages of testing before being rolled out. Multiple experts have said vaccines that have not been properly tested can be detrimental in many ways, negatively impacting health or creating a false sense of security. What is more dangerous is that they can undermine trust in all vaccines.

While the world is understandably desperate for immunisation against Covid-19 due to the colossal toll the infection has taken on all aspects of life, jumping the gun when it comes to health matters can have dangerous consequences. Countries must proceed ethically and with caution before considering the mainstreaming of such a vaccine.

Published in Dawn, August 14th, 2020

Opinion

Editorial

Defining extremism
Updated 18 Mar, 2024

Defining extremism

Redefining extremism may well be the first step to clamping down on advocacy for Palestine.
Climate in focus
18 Mar, 2024

Climate in focus

IN a welcome order by the Supreme Court, the new government has been tasked with providing a report on actions taken...
Growing rabies concern
18 Mar, 2024

Growing rabies concern

DOG-BITE is an old problem in Pakistan. Amid a surfeit of public health challenges, rabies now seems poised to ...
Provincial share
Updated 17 Mar, 2024

Provincial share

PPP has aptly advised Centre to worry about improving its tax collection rather than eying provinces’ share of tax revenues.
X-communication
17 Mar, 2024

X-communication

IT has now been a month since Pakistani authorities decided that the country must be cut off from one of the...
Stateless humanity
17 Mar, 2024

Stateless humanity

THE endless hostility between India and Pakistan has reduced prisoners to mere statistics. Although the two ...